[PDF] Top 20 Barreras de acceso a los servicios de salud en la comunidad transgénero y transexual
Has 10000 "Barreras de acceso a los servicios de salud en la comunidad transgénero y transexual" found on our website. Below are the top 20 most common "Barreras de acceso a los servicios de salud en la comunidad transgénero y transexual".
<p>Treatment patterns and economic outcomes in patients with juvenile idiopathic arthritis</p>
... of treatment costs were from TNFi use. High disease and treatment costs paired with low treatment adherence and persistence at one year suggest a need for employing a broader range of ... See full document
13
Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis
... cancer patients re- ceiving chemotherapy treatment and has a reported fre- quency of 30% [11], it has only been assessed in a few studies of children with JIA (Table ...of patients experienced ... See full document
8
Clinical improvement of renal amyloidosis in a patient with systemic-onset juvenile idiopathic arthritis who received tocilizumab treatment: a case report and literature review
... for treatment of SJIA; remission was achieved in less than half of all patients in these studies, and relapsing disease was common ...15 patients with amyloidosis with underlying rheumatic diseases ... See full document
24
Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis
... sJIA patients with elevated levels of sCD25 in combination with multiple other laboratory abnor- malities suggestive of MAS were identified [26], indicat- ing early immunological derailment prior to the ... See full document
41
Clinical patterns of juvenile idiopathic arthritis in Zambia
... The patients had been referred by their primary care health facilities within Lusaka and from other parts of ...1994–98 patients were evaluated prospectively by PN in an adult rheumatology clinic setting, ... See full document
6
The new Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry: design, rationale, and characteristics of patients enrolled in the first 12 months
... of treatment with methotrexate or a biologic agent, irrespect- ive of whether this occurs at a routine 6-month follow-up ...the Juvenile Arthritis Disease Activity Score (JADAS) [22, 23], and the ... See full document
11
Persistence and adverse events of biological treatment in adult patients with juvenile idiopathic arthritis: results from BIOBADASER
... of patients who undergoing biologic therapies [26, ...All patients included in the BIOBADASER registry, or their legal representatives, signed a written informed consent prior to ... See full document
16
Treatment of juvenile idiopathic arthritis: a revolution in care
... RCT of both etanercept and adalimumab demonstrated TNFi to be effective therapeutic options for children with polyarticular course JIA, with withdrawal studies demon- strating fewer flares among the drug- versus placebo- ... See full document
14
Tofacitinib Treatment of Refractory Systemic Juvenile Idiopathic Arthritis
... Systemic juvenile idiopathic arthritis (sJIA) is an aggressive form of childhood arthritis accompanied by persistent systemic ...inflammation. Patients with sJIA often exhibit poor ... See full document
5
Tocilizumab in the treatment of systemic juvenile idiopathic arthritis
... of patients, respectively, again indicating strong and rapid therapeutic efficacy of tocilizumab (Figure ...respectively, P , 0.0001). Patients treated with tocilizumab in the double-blind phase were ... See full document
6
Role of Interleukin 1 Alpha (IL 1α) and Interleukin 1 Receptor Antagonist (IL 1RA) in Pathogenesis of Juvenile Idiopathic Arthritis and Adult Onset Rheumatoid Arthritis of Iraqi Patients
... This cytokine is strongly expressed by monocytes, tissue macrophages and dendritic cells, but B, NK and epithelial cells are also producer of IL-1 (Dinarello, 2011). Both types of IL-1 (IL-1α and IL-1β) exert their ... See full document
16
Challenges in the management of juvenile idiopathic arthritis with etanercept
... the treatment of active poly-articular juvenile idiopathic arthritis (JIA) in children aged 4 to 17 years who have failed to respond to methotrexate alone, or who have been intolerant of ... See full document
193
<p>Visual Function And Quality Of Life In A Cohort Of Swedish Children With Juvenile Idiopathic Arthritis</p>
... in patients with JIA and ...functional outcomes in children with chronic ...the patients were relatively stable in their JIA, but also due to the few cases with uveitis and/or other ocular ... See full document
22
<p>Depression And Anxiety In Patients With Juvenile Idiopathic Arthritis: Current Insights And Impact On Quality Of Life, A Systematic Review</p>
... JIA treatment on symptoms of depres- sion and anxiety was rarely approached in the reviewed studies; however, our search approach was not wide enough to include studies of treatments that reported symptoms of ... See full document
17
Time to diagnosis in juvenile idiopathic arthritis: a french perspective
... for patients with rheumatic diseases, with a growing number of opportunities for young paediatricians to access accurate medical education in paediatric ...JIA patients in ...for patients and their ... See full document
6
Patient perceptions of foot disability in Juvenile Idiopathic Arthritis: a comparison of the juvenile arthritis foot disability index and the Oxford ankle foot questionnaire for children
... with Juvenile Idiopathic Arthritis (JIA) which has a prevalence of approximately 1 in 1000 children in the UK ...the treatment to be patient-centred ensuring that the patient drives a ... See full document
138
Methotrexate polyglutamates as a potential marker of adherence to long term therapy in children with juvenile idiopathic arthritis and juvenile dermatomyositis: an observational, cross sectional study
... 17 patients receiving stable weekly doses of MTX, which is indicative of nonadherence or partial adherence to MTX ...( P = 0.026) and route of administration ( P = ...( P < 0.001 and ... See full document
22
<p>Review of environmental factors and juvenile idiopathic arthritis</p>
... Evidence on the role of environmental factors in the development of JIA is slowly expanding, including poten- tial protective in fl uences from breast feeding and house- hold siblings and potential risks from antibiotic ... See full document
7
Juvenile idiopathic arthritis in adulthood: fulfilment of classification criteria for adult rheumatic diseases, long term outcomes and predictors of inactive disease, functional status and damage
... in patients with predominant axial involvement, as the ones classi fi ed as AS, who represent ...of patients with active disease is because JIA categories with better outcomes, as persistent ... See full document
124
The effect of immunomodulators on the immunogenicity of TNF blocking therapeutic monoclonal antibodies: a review
... 442 patients were assessed for the presence of ...of patients developed ATIs, and 46% had an inconclusive ...the patients receiving concomitant steroids and immuno- modulators, 17% of the ... See full document
6
Related subjects